Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 10 Issue 12, December 2014

Using a modified version of the in silico screening tool, DOCK, compounds that covalently modify catalytic and noncatalytic protein nucleophiles find compounds that modulate the activities of bacterial β-lactamase (AmpC) and the kinases RSK2, MSK1 and JAK3, including a first-in-class inhibitor for JAK3. Shown is a new JAK3 reversible covalent inhibitor docked to JAK3 (white) sampled at different orientations around the covalent bond to the active site cysteine (rainbow). Cover art by Erin Dewalt, based on an image from Brian Shoichet. Article, p1066

Research Highlights

Top of page ⤴

News & Views

  • In the assembly of metalloenzymes, the matching of metals and proteins must occur with absolute precision. When zinc-starved, Chlamydomonas maintains its balance of metals by sequestering copper in electron-dense traps for metals, thus preventing mishaps in protein metallation.

    • Valeria Culotta
    News & Views
  • The dynamic interplay between p53 and Mdm2 triggers cell cycle arrest after DNA damage. A new study reveals that disorder in the transactivation domain of p53 is important for tuning this negative feedback system to ensure normal cellular signaling responses.

    • Richard W Kriwacki
    News & Views
  • The small molecule inflachromene was discovered as a microglia-selective inhibitor of the central nervous system proinflammatory response and found to target HMGB2 and HMGB1 to impair proinflammatory signaling in microglia, resulting in neuroprotection.

    • Michelle L Block
    News & Views
Top of page ⤴

Review Article

  • Carbohydrate antigens on HIV are important for viral biology as well as for recognition by glycan-reactive broadly neutralizing antibodies such as 2G12. A review of recent strategies targeting HIV glycans discusses the characterization and manipulation of glycopeptide epitopes for use as potential vaccines.

    • Satoru Horiya
    • Iain S MacPherson
    • Isaac J Krauss
    Review Article
Top of page ⤴

Brief Communication

Top of page ⤴

Article

Top of page ⤴

Erratum

Top of page ⤴

Search

Quick links